The UK private GP EHR market is expected to grow due to advances in medical technology and an increasing demand for private GP services. Private GP services are proving popular due to declining numbers of NHS general practitioners and a scarcity of primary physicians. Technological advancements may also drive demand with AI and wearable technology integration. However, cybersecurity and technical issues could hinder market growth.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
